Trupanion, Inc. TRUP

Zacks Investment Research 6 nov

The Accident & Health Insurance industry faces pricing pressures and rising medical costs, but benefits from increased demand for supplemental health products and technology adoption. Five insurers—Aflac, Unum Group, Globe Life, Trupanion, and Employers Holdings—are highlighted as potential investments despite industry headwinds. The industry carries a Zacks Industry Rank #196 (bottom 21%), though it has outperformed the broader market year-to-date.

Zacks Investment Research 5 nov

Trupanion reported Q3 2026 earnings of $0.21 per share, beating consensus estimates of $0.16, with revenues of $405.59 million slightly exceeding expectations. However, the stock has underperformed the S&P 500 by 22.2% year-to-date. The company received a Zacks Rank #3 (Hold) rating with mixed estimate revisions. Meanwhile, Oaktree Specialty Lending is expected to report a 15% year-over-year earnings decline when it releases results on November 17.

Zacks Investment Research 5 nov

Trupanion reported Q3 2026 revenue of $405.59 million, up 10.5% year-over-year, beating the consensus estimate of $402.16 million by 0.85%. EPS came in at $0.21, significantly exceeding the estimate of $0.16 by 31.25%. The subscription business revenue grew 13.9% to $287.9 million, while subscription adjusted operating income reached $45.38 million, surpassing analyst expectations. The stock has gained 36.7% over the past month and carries a Zacks Rank #3 (Hold) rating.

Zacks Investment Research 5 nov

The Accident and Health Insurance industry faces pricing pressures and medical inflation challenges, but benefits from growing demand for supplemental health insurance and technology adoption. Despite outperforming the S&P 500 year-to-date with a 12.2% gain, the industry carries a weak Zacks Industry Rank #196, reflecting negative earnings outlooks. Five stocks are highlighted as potential holdings with mixed growth prospects.

Zacks Investment Research 4 nov

Aflac reported Q3 2026 earnings of $2.43 per share, significantly beating the consensus estimate of $1.80 per share, representing a 35% earnings surprise. Revenue of $4.3 billion also exceeded expectations by 2.21%. However, the stock received a Zacks Rank #3 (Hold) rating, suggesting near-term performance in line with the market. The Insurance - Accident and Health industry ranks in the bottom 31% of Zacks industries.